Skip to main content
Boule Diagnostics logo

Boule Diagnostics — Investor Relations & Filings

Ticker · BOUL ISIN · SE0011231158 LEI · 213800IK1TGY858TKZ45 ST Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2016-11-03 Major Shareholding Noti…
Country SE Sweden
Listing ST BOUL

About Boule Diagnostics

https://boule.com/

Boule Diagnostics is a global provider of diagnostic solutions specializing in hematology. The company develops, manufactures, and markets systems and consumables for blood diagnostics, including hematology analyzers, clinical chemistry analyzers, and associated reagents, controls, and calibrators. Its products are tailored for decentralized healthcare settings in both the human and veterinary markets, such as smaller laboratories and clinics. The company aims to enhance global healthcare access by providing high-quality instruments that deliver timely and accurate blood test results.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for SEB Investment Management AB in Boule Diagnostic AB. It explicitly shows the 'Before the transaction' and 'After the transaction' share quantities and voting rights percentages, culminating in a new total holding of 9.33% (439,086 shares). This structure—reporting changes in significant ownership levels crossing a threshold—directly matches the definition for Major Shareholding Notification (MRQ). The document is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2016-11-03 English
Boule Diagnostics vinner upphandling till Röda Korset i Kenya
Regulatory Filings Classification · 1% confidence The document is a short press release dated 2016-10-17 announcing a significant contract win by Boule Diagnostics AB with the Red Cross in Kenya. It details the scope of the contract (hematology systems delivery in Q4 2016) and includes a quote from the CEO. Crucially, the final paragraph states: "Denna information är sådan som Boule Diagnostics AB är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning" (This information is such that Boule Diagnostics AB is required to make public pursuant to the EU's Market Abuse Regulation). This indicates a mandatory regulatory disclosure, but it is not a standard SEC form (like 10-K, ER, or DIV). Since it is a specific, material announcement that doesn't fit the other specific categories (like M&A, Capital Change, or Director Dealing), the most appropriate classification is the general regulatory announcement fallback category, RNS (Regulatory Filings). The document length is very short (1799 chars), confirming it is an announcement, not a full report.
2016-10-17 Swedish
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for Boule Diagnostic AB by SEB Asset Management S.A. Specifically, it reports the 'Reason for major shareholding notification Buy' and provides the resulting share quantity (333,400) and percentage (7.08%). This content directly aligns with the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing specified thresholds (here, 5%). Therefore, the appropriate filing type code is MRQ.
2016-10-03 English
Boule Diagnostics vinner kontrakt i USA
Regulatory Filings Classification · 1% confidence The document is a short press release announcing a significant contract win in the USA by Boule Diagnostics. It details the agreement, quotes the CEO, and provides company background. This type of announcement, which is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial update (like DIV or CAP), falls best under the general category for regulatory announcements or news releases that don't fit elsewhere. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general, material, non-standardized announcement, although it is essentially a press release. Since there is no specific category for 'Press Release' or 'Material Contract Announcement', RNS serves as the best fit among the provided codes for a general regulatory disclosure.
2016-08-26 Swedish
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding for an issuer (Boule Diagnostic AB) by a holder (Nordea Funds Oy). It explicitly states the 'Reason for major shareholding notification Sell' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage of voting rights (7.984%). This structure perfectly matches the definition of a Major Shareholding Notification, which is classified as 'MRQ'. The document is short and focuses purely on the transaction details, not a full report or an announcement of a report.
2016-08-02 English
Interim / Quarterly Report 2016
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the period of April–June 2016 and January–June 2016 (interim period). It contains detailed financial statements, including income statements, cash flow analysis, balance sheet data, and management commentary on business performance, risks, and market outlook. It is clearly an interim/quarterly report rather than a simple earnings release or a publication announcement, as it provides substantive financial data and analysis. H1 2016
2016-08-01 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.